diabetes mellitus/edema

FIELD OF THE INVENTION The invention relates to taking the five crystalline forms of compound, XLF-III-43, as crude drug, the preparation methods of the five crystalline forms of XLF-III-43, taking the sterling of the five crystalline forms and mixed crystals with different proportions as active

FIELD OF THE DISCLOSURE The present disclosure is directed to methods for the treatment and prevention of nephrotic syndrome and conditions related thereto, such as, but not limited to, proteinuria and edema. BACKGROUND Nephrotic syndrome (NS) is a general term that refers to the loss of protein in

FIELD OF THE DISCLOSURE The present disclosure is directed to methods for the treatment and prevention of nephrotic syndrome and conditions related thereto, such as, but not limited to, proteinuria and edema. BACKGROUND Nephrotic syndrome (NS) is a general term that refers to the loss of protein in

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a new substance BPC, the process for its preparation from human or animal gastric juice and its use in the therapy. 2. Description of the Prior Art Gastric juice, considered as a secretion of the parietal as well

CROSS REFERENCE TO RELATED APPLICATION The present invention is based on, and claims priority from 60/008,390, filed Dec. 8, 1995. BACKGROUND OF THE INVENTION This application is directed to inhibitors of nitric oxide synthase, and in particular substituted azacycle derivatives. Nitric Oxide in

BACKGROUND OF THE INVENTION This application is directed to inhibitors of Nitric oxide synthase, and in particular cyclic amidines. Nitric Oxide in Biology. The emergence of nitric oxide (NO), a reactive, inorganic radical gas as a molecule contributing to important physiological and pathological